|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1997-6-3
|
|
pubmed:abstractText |
Currently bone marrow transplantation (BMT) with an HLA-identical sibling donor is recommended as optimal therapy for children with acquired severe aplastic anemia (SAA). Immunosuppressive therapy (IST) has become a very successful initial therapy for SAA in children lacking a related bone marrow donor. We wished to evaluate whether current IST regimens may be as efficacious as BMT.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1077-4114
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
115-23
|
|
pubmed:dateRevised |
2011-10-6
|
|
pubmed:meshHeading |
pubmed-meshheading:9149740-Adolescent,
pubmed-meshheading:9149740-Anemia, Aplastic,
pubmed-meshheading:9149740-Bone Marrow Transplantation,
pubmed-meshheading:9149740-British Columbia,
pubmed-meshheading:9149740-Child,
pubmed-meshheading:9149740-Child, Preschool,
pubmed-meshheading:9149740-Humans,
pubmed-meshheading:9149740-Immunosuppressive Agents,
pubmed-meshheading:9149740-Infant,
pubmed-meshheading:9149740-Retrospective Studies,
pubmed-meshheading:9149740-Survival Analysis,
pubmed-meshheading:9149740-Treatment Outcome
|
|
pubmed:articleTitle |
Immunosuppressive therapy: a potential alternative to bone marrow transplantation as initial therapy for acquired severe aplastic anemia in childhood?
|
|
pubmed:affiliation |
Division of Pediatric Hematology-Oncology and Bone Marrow Transplantation, University of British Columbia, Vancouver, Canada.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
